Shulman De Meo Asset Management LLC Astrazeneca PLC Transaction History

Shulman De Meo Asset Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$48.42 - $60.18 $433,746 - $539,092	-8,958 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$47.16 - $54.44 $141 - $163	3 Added 0.03%	8,958 $445,000
Q4 2020 Jan 13, 2021	SELL	$48.52 - $58.02 $17,418 - $20,829	-359 Reduced 3.85%	8,955 $448,000
Q3 2020 Nov 02, 2020	BUY	$53.07 - $61.1 $265 - $305	5 Added 0.05%	9,314 $510,000
Q1 2020 Apr 10, 2020	SELL	$37.79 - $51.33 $66,812 - $90,751	-1,768 Reduced 15.96%	9,309 $416,000
Q4 2019 Jan 15, 2020	SELL	$42.46 - $50.46 $849 - $1,009	-20 Reduced 0.18%	11,077 $552,000
Q3 2019 Oct 30, 2019	BUY	$40.12 - $45.47 $119,437 - $135,364	2,977 Added 36.66%	11,097 $495,000
Q2 2019 Jul 18, 2019	BUY	$37.28 - $41.68 $59,536 - $66,562	1,597 Added 24.48%	8,120 $335,000
Q1 2019 May 01, 2019	BUY	$35.49 - $43.02 $231,501 - $280,619	6,523 New	6,523 $264,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $208B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Shulman De Meo Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Shulman De Meo Asset Management LLC with notifications on news.